National Health Research Institutes Business Matchmaking Session (2023 BIO Asia-Taiwan) – Precision biomedical technology, health care & Smart medicine

Time: 13:20-16:30, July 28, 2023 (Friday)

Venue: Conference room 500, 5F Taipei Nangang International Exhibition Center, Hall1 (On-site)

Fee: Free of charge

On-line registration: Click here (Accept on-site registration)


Time Subject Speakers
13:20~13:25 Opening remarks NHRI

Wei J. Chen, Vice President

13:25~13:30 Brief of the agenda

Procedures for industry-academia collaboration

Procedures for technology transfer

Hua-hsuan Liang (TTIC)

Tsui-hui Wu (TTIC)

13:30~13:40 Precision epidemic prevention: Targeted antigen National Institute of Infectious Diseases and Vaccinology (NIIDV)

Hsin-Wei Chen, Deputy Director

13:40~13:50 Precision epidemic prevention: Mucosal adjuvant
13:50~14:00 Precision epidemic prevention: Assembly teaching aid in immunology Immunology Research Center

Yu-wen Su, Associate PI

14:00~14:10 Precision medicine: A Novel broad spectrum cancer immunotherapeutic agent targeting CD47-SIRPα “Don’t eat me” signaling axis Institute of Biotechnology and Pharmaceutical Research (IBPR)

Wan-Ching Yen, Senior PI

14:10~14:20 Precision medicine: Discovery of a novel antibody-drug conjugate (ADC) for the potential treatment of cancer cells expressing neurotensin receptor 1 (NTSR1) Yueh Andrew Yueh, Senior PI (IBPR)
14:20~14:30 Precision medicine: A novel small-molecule neuroprotective drug for preventing chemotherapy-induced peripheral neuropathy Yi-Fan Chen, Postdoctoral Researcher (IBPR)
14:30~14:40 Precision health care: A new method to enhance the safety of ketamine in treating depression Center for Neuropsychiatric Research

Hwei-Hsien Chen, Senior PI

14:40~14:50 Introduction of Taiwan Universe Biomedicine (Tai-U, a NHRI start-up company) Min-Shi Lee, Senior PI (NIIDV)
14:50~15:00 DEEP01 LIMITED

DeepCT – World-leading AI-based Brain CT Clinical Decision Support System

David Chou
15:00~15:10 LuminX Biotech Co.,Ltd

The Reincarnation of Cells – Cellular Tracking for Therapy Impact Analysis

Dr. Harry Su, Founder & CEO
15:10~15:20 Acura Nanomedicine Inc.

Multi-Target Anti-Cancer Strategy of AN-845 & Advanced Nano-Delivery Vehicle Platforms of Acura NanoMedicine

Brian Hsu

Next Generation MRgHIFU – ArcBlate System

Dr. Kai Chang, Medical Director at EpiSonica
15:30~15:40 Jubilee International Biomedical Co., Ltd.

Revolutionary Technology in Healthcare and Beauty – Low-Temperature Cold Plasma

Liu Chih Tung / CTO

Exosome-Based Liquid Biopsy for Differential Diagnosis of Triple-Negative Breast Cancer

Weicheng Su / Chief Operating Officer
15:50~16:00 Taiwan Genomic Industry Alliance Inc.

Unraveling the Human Genome: Comprehensive Profiling through NovaSeq X Sequencing and Advanced TGIA Analysis Techniques.

Dr. Lin, Chien-Hsing Ph.D.


16:00~16:10 BioLASCO Taiwan Co., Ltd.

From experimental animals to animal experiments solutions

Hank Chen, the President of BioLASCO Taiwan Co., Ltd.
16:10~16:20 ITAMINS

Strategic Biomedical Marketing

Tzu-Hua Weng, MD/Ph.D.

Justine Yang, CEO

16:20~16:30 Taiwan Web Service Corporation

OneAI – High performance computing and biomedical AI generate new value for precision medicine

Jamie Chang / Product Manager

Contact us: Technology Transfer & Incubation Center, NHRI

Ms. Tsui-hui Wu or Mr. Richard Yeh at 886+ 37-206166 ext.33202 or 33212

OrganizerNational Health Research Institutes

Co-organizerTaiwan Web Service Corporation (TWS)

SponsorMinistry of Health and Welfare

Small and Medium Enterprise Administration, MOEA